Immunomedics (IMMU) Misses Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Immunomedics Announces Third Quarter Fiscal 2016 Results and Clinical Program Developments
May 4, 2016 4:00 PM EDTMORRIS PLAINS, N.J., May 04, 2016 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (Nasdaq: IMMU) today reported financial results for the third quarter ended March 31, 2016. The Company also highlighted recent key developments and planned activities for its clinical pipeline.
Third Quarter Fiscal 2016 Results
Total revenues for the third quarter of fiscal year 2016,... More
